INVESTABOT
Equity Research
XNAS · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Moderna appointed Juan Andres as its first-ever Chief Operating Officer, effective October 5, 2026, with a $800,000 base salary and up to $5 million in new hire equity. The move signals that Moderna is building…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-09-14. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-08-05. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-09-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-09-10. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-09-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-07-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-06-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-06-18. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-06-04. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-21. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 5 unique sellers · Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 15, 2026 | Hoge Stephen | President | OPTION_EXERCISE | -76,452 | — | — |
| September 15, 2026 | Hoge Stephen | President | SELL | -40,281 | $146 | ~$5.9M |
| September 15, 2026 | Hoge Stephen | President | OPTION_EXERCISE | 76,452 | $12 | ~$0.9M |
| September 14, 2026 | Hoge Stephen | President | OPTION_EXERCISE | -76,453 | — | — |
| September 14, 2026 | Hoge Stephen | President | SELL | -40,294 | $144 | ~$5.8M |
| September 14, 2026 | Hoge Stephen | President | OPTION_EXERCISE | 76,453 | $12 | ~$0.9M |
| September 10, 2026 | Mock James M | Chief Financial Officer | OPTION_EXERCISE | -19,836 | — | — |
| September 10, 2026 | Mock James M | Chief Financial Officer | SELL | -15,000 | $134 | ~$2.0M |
| September 10, 2026 | Mock James M | Chief Financial Officer | SELL | -19,836 | $134 | ~$2.7M |
| September 10, 2026 | Mock James M | Chief Financial Officer | OPTION_EXERCISE | 19,836 | $31 | ~$0.6M |
| September 4, 2026 | Mock James M | Chief Financial Officer | OPTION_EXERCISE | 11,797 | — | — |
| September 4, 2026 | Mock James M | Chief Financial Officer | TAX_WITHHOLD | -5,704 | $149 | ~$0.8M |
| September 4, 2026 | Mock James M | Chief Financial Officer | OPTION_EXERCISE | -11,797 | — | — |
| September 4, 2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | 11,797 | — | — |
| September 4, 2026 | Klinger Shannon Thyme | Chief Legal Officer | TAX_WITHHOLD | -5,704 | $149 | ~$0.8M |
| September 4, 2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | -11,797 | — | — |
| September 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | 3,471 | $31 | ~$0.1M |
| September 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | SELL | -3,471 | $140 | ~$0.5M |
| September 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | 2,166 | — | — |
| September 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | TAX_WITHHOLD | -1,048 | $140 | ~$0.1M |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| September 15, 2026 | Hoge Stephen | — | 40,281 | SEC |
| September 14, 2026 | Hoge Stephen | — | 40,294 | SEC |
| September 10, 2026 | Mock James M | — | 34,836 | SEC |
| September 1, 2026 | Klinger Shannon Thyme | — | 3,471 | SEC |
| August 5, 2026 | Bancel Stephane | — | 499,246 | SEC |
| July 15, 2026 | Hoge Stephen | — | 53,336 | SEC |
| June 18, 2026 | Sagan Paul | — | 25,770 | SEC |
| June 15, 2026 | Hoge Stephen | — | 53,336 | SEC |
| June 4, 2026 | Klinger Shannon Thyme | — | 3,471 | SEC |
| May 21, 2026 | Flagship Pioneering, LLC | — | 9,263 | SEC |